RHONE-POULENC RORER PHARMACEUTICALS INC.
Patent Owner
Stats
- 21 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 30, 2013 most recent publication
Details
- 21 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,569 Total Citation Count
- May 02, 1977 Earliest Filing
- 177 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
RE36256 Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseDec 10, 97Jul 20, 99[A61K, C07D]
5795889 Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseFeb 09, 95Aug 18, 98[A61K, C07D]
5710254 Purification of von Willebrand factor by affinity chromatographyJun 07, 95Jan 20, 98[A61K, C07K]
5656643 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseFeb 08, 95Aug 12, 97[A61K, C07D]
5646153 Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinaseMay 11, 95Jul 08, 97[A61K]
5597837 Method and composition for treating psoriasis with styryl-substituted pyridyl compoundsApr 11, 94Jan 28, 97[A61K]
5596020 Amino bi- and tri-carbocyclic alkane bis-aryl squalene synthase inhibitorsDec 07, 94Jan 21, 97[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8431119 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseasesExpiredAug 22, 07Apr 30, 13[A61K, A01N, C12N]
6187548 Methods using human calcium sensor protein, fragments thereof and DNA encoding sameExpiredMay 23, 96Feb 13, 01[G01N]
6143894 Preparation of [1S-[1A,2B,3B,4A(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl propyl]amino] -3H-imidazo[4,5-B]pyridin-3-yl]-N-ethyl-2,3-dihydroxycyclopentanecarboxa mideExpiredJan 19, 99Nov 07, 00[C07D]
5730713 Removal of selected factors from whole blood or its componentsExpiredJun 03, 96Mar 24, 98[A61K, A61M]
5677329 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinaseExpiredMay 19, 95Oct 14, 97[A61K, C07D]
5674482 Polymers with alkyl- or heteroalkyl -aryl backbone and pharmaceutical compositions incorporating sameExpiredAug 09, 91Oct 07, 97[A61K, C08G]
5656655 Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinaseExpiredMay 19, 95Aug 12, 97[A61K, C07D]
5571506 Aromatic oligomeric compounds useful as mimics of bioactive macromoleculesExpiredSep 10, 93Nov 05, 96[A61K, C08G]
5561143 Aliphatic amino bis-aryl squalene synthase inhibitorsExpiredMay 22, 95Oct 01, 96[A61K, C07D]
5550161 Substituted orally effective ION chelators related to deferoxamineExpiredOct 28, 93Aug 27, 96[A61K]
5541109 Expression cloning of c-src SH3-domain binding proteinsExpiredApr 19, 94Jul 30, 96[C07H, C12N]
5534532 Aliphatic amino bis-aryl squalene synthase inhibitorsExpiredJan 25, 95Jul 09, 96[A61K, C07D]
5523096 Removal of selected factors from whole blood or its componentsExpiredJun 06, 95Jun 04, 96[A61K, A61M]
5451596 Cycloalkyl amine bis-aryl squalene synthase inhibitorsExpiredDec 29, 92Sep 19, 95[A61K, C07D]
5437861 Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndromeExpiredMar 16, 93Aug 01, 95[A61K, A01N, A61M, B01D]
5340801 Compounds having cholecystokinin and gastrin antagonistic propertiesExpiredMay 08, 91Aug 23, 94[A61K, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
